News in the Life Sciences Industry

TAIPEI, Taiwan, Jan. 21, 2020 /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-999 for the treatment of Gastric Cancer. OBI-999 is a first-in-class antibody drug... Read more ››

SAN DIEGO, Jan. 14, 2020 /PRNewswire/ -- My Green Lab is pleased to announce a collaboration with AstraZeneca to implement a global-scale green labs program across their research sites as part of their commitment to sustainability, including protecting the environment.

SHUZHOU, China, Jan. 2, 2020 /PRNewswire/ -- CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included participation... Read more ››

TAIPEI, Taiwan, Dec. 26, 2019 /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-999 for the treatment of Pancreatic Cancer. OBI-999 is a first-in-class antibody... Read more ››

SINGAPORE, Dec. 17, 2019 /PRNewswire/ -- Manufacturing Automation Asia organized by Centre for Management Technology (CMT) will be held in advanced manufacturing hub - Singapore, the summit brings together key insights from manufacturers who have already adopted Read more ››

TAIPEI, Dec. 3, 2019 /PRNewswire/ -- Opioid misuse, addiction, and overdoses have caused significant social and economic burdens leading to the opioid crisis. LT1001 (brand name Naldebain®) is a prodrug of nalbuphine, an abuse-free analgesic that has been marketed worldwide for decades. Naldebain®... Read more ››